Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation

被引：33

作者：

Nix, David E. ^{[1
]}

Matthias, Kathryn R. ^{[1
]}

机构：

[1] Univ Arizona, Tucson, AZ 85721 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2010年 / 65卷 / 06期

关键词：

urinary tract infections; tetracyclines; pharmacokinetics; multidrug resistance; MDR KLEBSIELLA-PNEUMONIAE; RECURRENT UROSEPSIS;

D O I：

10.1093/jac/dkq116

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1311 / 1312

页数：2

共 6 条

[1] Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection [J].

Cunha, B. A. ;

Mcdermot, B. ;

Nausheen, S. .

JOURNAL OF CHEMOTHERAPY, 2007, 19 (06) :753-754

[2] Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis [J].

Cunha, Burke A. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) :1613-1613

[3] Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective [J].

Curcio, Daniel .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (05) :1892-1893

[4] Metabolism, excretion, and pharmacokinetics of [14C] tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects [J].

Hoffmann, Matthew ;

DeMaio, William ;

Jordan, Ronald A. ;

Talaat, Rasmy ;

Harper, Dawn ;

Speth, John ;

Scatina, JoAnn .

DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) :1543-1553

[5] Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-β-lactamase-producing Escherichia coli [J].

Krueger, Wolfgang A. ;

Kempf, Volkhard A. J. ;

Peiffer, Manou ;

Nagele, Udo ;

Unertl, Klaus E. ;

Schroeder, Torsten H. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) :817-820

[6] Tigecycline pharmacokinetic/pharmacodynamic update [J].

MacGowan, Alasdair P. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 :I11-I16

← 1 →